Peptides and uses thereof for treating cancer
AssigneeSymthera Canada Ltd.
InventorChai Ezerzer
Life of this patent
Estimating the term…
Abstract
Presented herein are cancer peptide agents and uses thereof for treating cancer and/or inhibiting metastasis. Also presented herein are methods of treating cancer, or inhibiting metastasis of cancer in a subject, comprising administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents to the subject. Also presented herein is a method of treating a cancer in a subject, or inhibiting metastasis of a cancer in a subject that comprises administering a therapeutically effective amount of a composition comprising one or more cancer peptide agents, and administering a chemotherapy or chemotherapeutic agent.
Claims17
A pharmaceutical composition comprising a cancer treating therapeutically effective amount of one or more cancer peptide agents consisting of an amino acid sequence selected from the group consisting of DVWSLGCILY (SEQ ID NO:6), DVWSIGCIMY (SEQ ID NO:7), DVWSMGILLY (SEQ ID NO:8), DIWSLGCLLY (SEQ ID NO:9), and DVWSLGCLLY (SEQ ID NO:14), and benzalkonium chloride.
A method of treating cancer in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a composition comprising one or more cancer peptide agents and benzalkonium chloride, wherein the one or more cancer peptide agents consists of an amino acid sequence selected from the group consisting of DVWSLGCILY (SEQ ID NO:6), DVWSIGCIMY (SEQ ID NO:7), DVWSMGILLY (SEQ ID NO:8), DIWSLGCLLY (SEQ ID NO:9), and DVWSLGCLLY (SEQ ID NO:14).
A method of treating cancer in a subject in need thereof comprising administering a therapeutic amount of a composition comprising a cancer peptide agent consisting of the amino acid sequence of DIWSLGCLLY (SEQ ID NO:9).
Dependencies are inferred from the claim text.